Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Sandrine Faivre

1-50 of 153 results

View this query on the Wikidata Query Service
Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer

scientific article
Current development of mTOR inhibitors as anticancer agents

scientific article
Molecular basis for sunitinib efficacy and future clinical development

scientific article published on September 2007
Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancer

scientific article
Targeting the TGFβ pathway for cancer therapy.

scientific article
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.

scientific article
Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation

scientific article
Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study

scientific article
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.

scientific article
Oxaliplatin: mechanism of action and antineoplastic activity

scientific article published on 01 April 1998
New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.

scientific article published on August 2006
Cellular and molecular pharmacology of oxaliplatin.

scientific article
Lessons learned in the development of targeted therapy for malignant gliomas.

scientific article published on July 2007
Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin

article
MEK in cancer and cancer therapy

scientific article published on 09 October 2013
Unraveling galectin-1 as a novel therapeutic target for cancer

scientific article published on August 1, 2013
Phase II study of sunitinib in recurrent or metastatic squamous cell carcinoma of the head and neck: GORTEC 2006-01.

scientific article published on 16 November 2009
Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumors.

scientific article
Supraadditive effect of 2',2'-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines.

scientific article published on January 1999
Targeting cancer cell metabolism in pancreatic adenocarcinoma

scientific article published on July 2015
Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas

scientific article published on January 2014
mTORC1 inhibitors: is temsirolimus in renal cancer telling us how they really work?

scientific article published on 16 September 2008
Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies

scientific article published on 6 September 2010
Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial

scientific article
Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenib.

scientific article published on 20 March 2014
Novel TGF-β inhibitors ready for prime time in onco-immunology

scientific article published on 7 December 2016
Dosage adjustment and pharmacokinetic profile of irinotecan in cancer patients with hepatic dysfunction

scientific article published in November 2002
Cancer wars: natural products strike back

scientific article
New inhibitors of the mammalian target of rapamycin signaling pathway for cancer.

scientific article published on August 2010
Phase I and pharmacokinetic study of aplidine, a new marine cyclodepsipeptide in patients with advanced malignancies.

scientific article published on 19 September 2005
Changes in Tumor Density in Patients with Advanced Hepatocellular Carcinoma Treated with Sunitinib

scientific article published on 29 April 2011
Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients.

scientific article
Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab

scientific article
Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer

scientific article published in February 2004
Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patients.

scientific article published on 25 October 2011
End points for new agents in induction chemotherapy for locally advanced head and neck cancers.

scientific article
Sunitinib in Pancreatic Neuroendocrine Tumors: Updated Progression-Free Survival and Final Overall Survival From a Phase III Randomized Study

scientific article published on 10 November 2016
Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resection

scientific article published on 11 January 2011
Preclinical and clinical development of novel agents that target the protein kinase C family

scientific article published on August 2006
Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis

scientific article
Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma

scientific article
Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma

scientific article
Pharmacokinetic profile of cetuximab (Erbitux) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma

scientific article published in August 2005
OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis

scientific article published on July 16, 2014
Imatinib mesylate can induce objective response in progressing, highly expressing KIT adenoid cystic carcinoma of the salivary glands

scientific article published in September 2005
Subungual splinter hemorrhages: a clinical window to inhibition of vascular endothelial growth factor receptors?

scientific article published in August 2005
Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma

scientific article published on 2 December 2010
Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature.

scientific article
Phase I and pharmacokinetic study of E7070, a novel chloroindolyl sulfonamide cell-cycle inhibitor, administered as a one-hour infusion every three weeks in patients with advanced cancer

scientific article
Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cells

scientific article

Paulina is supported by:

About Paulina

Help